# Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

> **NCT04989829** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SHR6390、Omeprazole

## Key facts

- **NCT ID:** NCT04989829
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-27
- **Primary completion:** 2022-01-26
- **Final completion:** 2022-02-14
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989829, "Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04989829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*